Overview
Opportunistic infections are infections caused by pathogens that ordinarily cause little or no disease in people with healthy immune systems but become harmful when the body's defenses are weakened. They commonly affect individuals with HIV/AIDS, those undergoing cancer treatment, organ-transplant recipients on immunosuppressive drugs, and others with compromised immunity. Because the immune system is unable to keep these organisms in check, opportunistic infections can become severe or life-threatening, making their prevention, diagnosis, and treatment a central concern in clinical microbiology. Research in this area examines the organisms responsible, the populations at risk, and the management of infection in immunocompromised patients. Work published through OpenAccessPub includes a study of the prevalence and antifungal susceptibility of Candida species among hospital patients, alongside extensive research on HIV infection, antiretroviral therapy, co-infections, and outcomes in people living with HIV/AIDS, all of which bear directly on the host vulnerability and pathogens central to opportunistic infection. This page gathers peer-reviewed, open-access research relevant to clinical microbiology and opportunistic infections, supporting an evidence-based understanding of how these infections arise, who they affect, and how they are diagnosed and managed.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Socio-Economic and Demographic Pattern of HIV Occurrence Amongst Attendees in a Tertiary Care Hospital in Eastern India.
Demographics, Clinical Profile and Outcome among the HIV Infected Persons Hospitalized in the HAART Era in Barbados.
Squamous Cell Carcinoma of the Conjunctiva (Scc) and Human Immunodefisciency Virus (Hiv): What Reality in Ivory Coast Through 23 Cases?
Phytochemicals May Arrest HIV-1 Progression
Clinical and Immunological Beneficial Effects of Phyto V7 Consumption by HIV-1 Seropositive Individuals
Pattern of Use of Highly Active Antiretroviral Therapy Regimens and Pattern of Occurrence of Adverse Drug Reactions in an Indian Human Immunodeficiency Virus Positive Patients
Invivo Impact of Malaria and HIV Co-Infection on CD4 Cell Count of Infected Patients of Niger Delta Extraction
Synthesis of Labeled Rifabutin Dithiocarbamate: A Potential Mycobacterium Tuberculosis Imaging Agent
How Harm Reduction Programs Work in The Context of Village and Commune Safety Policy: Lessons Learned from A National Non-Governmental Organization in Cambodia
A Cross Sectional Analysis of Frailty and Markers of Frailty in Young People Living with HIV/AIDS
Antiretroviral Pre-Exposure Prophylaxis Awareness, Experience and Acceptance among Men who have Sex with Men in Southwest Switzerland
How this research is being cited
The 12 articles above have been cited 12 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · The Natural Products Journal
-
2022 · Journal of Human Virology & Retrovirology
-
2019 · Radiochemistry
-
2019 · Radiochemistry
-
Synthesis of Labeled Rifabutin Dithiocarbamate: A Potential Mycobacterium Tuberculosis Imaging Agent2017 · Journal of Glycomics and Metabolism
-
Shamiya Sadiq et al. · 2016 ·
-
2016 · Journal of Human Virology & Retrovirology
-
2016 · Journal of Clinical Research in HIV AIDS and Prevention
A sample of recent works citing this journal's research on Opportunistic Infections, linking to each citing work.